Endothelial FSH receptor expression and vascular remodeling in hormone-refractory prostate cancer.

被引：0
|
作者：
Ghinea, Nicolae [1 ]
Robin, Blaise [1 ]
Planeix, Francois [1 ]
Brito, Isabel [1 ]
Pichon, Christophe [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Atrasentan: The first endothelin receptor antagonist for hormone-refractory prostate cancer
    Schulman, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 20 - 27
  • [32] Phase I trial of sargramostim and thalidomide for treatment of hormone-refractory prostate cancer.
    Lilly, M
    Rowsell, EH
    Gurrola, R
    Ruckle, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 429S - 429S
  • [33] Treatment with prednisolone of hormone-refractory prostate cancer
    Fuse, H
    Nozaki, T
    Fujiuchi, Y
    Mizuno, I
    Nagakawa, O
    Okumura, A
    ARCHIVES OF ANDROLOGY, 2006, 52 (01): : 35 - 38
  • [34] Octreotide in the management of hormone-refractory prostate cancer
    Vainas, IG
    CHEMOTHERAPY, 2001, 47 : 109 - 126
  • [35] Docetaxel (Taxotere) in hormone-refractory prostate cancer
    Petrylak, DP
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 24 - 29
  • [36] Revolutions in the management of hormone-refractory prostate cancer
    Abrahamsson, PA
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 1 - 2
  • [37] Therapeutic options for hormone-refractory prostate cancer
    Miller, K.
    Boergermann, C.
    Thueroff, J.
    Albers, P.
    Wirth, M.
    UROLOGE, 2006, 45 (05): : 580 - +
  • [38] Paclitaxel in the treatment of hormone-refractory prostate cancer
    Smith, DC
    Pienta, KJ
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 109 - 111
  • [39] Treatment options for hormone-refractory prostate cancer
    Heidenreich, A
    Ohlmann, CH
    UROLOGE, 2005, 44 (11): : 1303 - +
  • [40] Hormone-refractory prostate cancer: Therapeutic approach
    Pepe, A.
    Leonardi, V.
    Palmisano, V.
    Savio, G.
    Calabria, C.
    Laudani, A.
    Usset, A.
    Cusimano, M.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2005, 16 : 154 - 155
12345